StonvexLoading…
StonvexStonvexStonvexCore line items from UMH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $35.04M | $33.53M | $31.18M | $25.34M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $26.27M | $21.44M | $7.85M | $-4.97M |
EPS (Diluted) | $0.07 | $0.03 | $-0.15 | $-0.67 |
Total Assets | $1.70B | $1.56B | $1.43B | $1.34B |
Total Liabilities | $791.84M | $647.82M | $720.78M | $793.40M |
Cash & Equivalents | $72.10M | $99.72M | $57.32M | $29.79M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 84.85M | 81.91M | 67.98M | 57.59M |